Insights

Loading spinner
Gathering insights about Novartis Gene Therapies

Novartis Gene Therapies Tech Stack

Novartis Gene Therapies uses 8 technology products and services including Salesforce Einstein Analytics, Google Analytics 4, Lucidchart, and more. Explore Novartis Gene Therapies's tech stack below.

  • Salesforce Einstein Analytics
    Analytics
  • Google Analytics 4
    Analytics
  • Lucidchart
    Charting
  • PureCloud
    Contact Center Solutions
  • Calabrio
    Customer Experience Management
  • git
    Development
  • Hadoop
    Programming Languages
  • Express
    Web Frameworks

Media & News

Novartis Gene Therapies's Email Address Formats

Novartis Gene Therapies uses at least 1 format(s):
Novartis Gene Therapies Email FormatsExamplePercentage
First.Last@novartis.comJohn.Doe@novartis.com
89%
F.Last@novartis.comJ.Doe@novartis.com
5%
FiLast@novartis.comJoDoe@novartis.com
3%
FLast@novartis.comJDoe@novartis.com
3%

Frequently Asked Questions

Where is Novartis Gene Therapies's headquarters located?

Minus sign iconPlus sign icon
Novartis Gene Therapies's main headquarters is located at 2275 Half Day Road Suite 200 Bannockburn, Illinois 60015 United States. The company has employees across 3 continents, including North AmericaEuropeAfrica.

What is Novartis Gene Therapies's official website and social media links?

Minus sign iconPlus sign icon
Novartis Gene Therapies's official website is novartis.com and has social profiles on LinkedIn.

What is Novartis Gene Therapies's SIC code NAICS code?

Minus sign iconPlus sign icon
Novartis Gene Therapies's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Novartis Gene Therapies have currently?

Minus sign iconPlus sign icon
As of February 2026, Novartis Gene Therapies has approximately 1K employees across 3 continents, including North AmericaEuropeAfrica. Key team members include Head Of Strategy And Innovation Trial Monitoring: J. S.Associate Director, Supply Chain Logistics: M. L.Director, Us Medical Affairs Training And Capabilities: A. B.. Explore Novartis Gene Therapies's employee directory with LeadIQ.

What industry does Novartis Gene Therapies belong to?

Minus sign iconPlus sign icon
Novartis Gene Therapies operates in the Biotechnology Research industry.

What technology does Novartis Gene Therapies use?

Minus sign iconPlus sign icon
Novartis Gene Therapies's tech stack includes Salesforce Einstein AnalyticsGoogle Analytics 4LucidchartPureCloudCalabriogitHadoopExpress.

What is Novartis Gene Therapies's email format?

Minus sign iconPlus sign icon
Novartis Gene Therapies's email format typically follows the pattern of First.Last@novartis.com. Find more Novartis Gene Therapies email formats with LeadIQ.

How much funding has Novartis Gene Therapies raised to date?

Minus sign iconPlus sign icon
As of February 2026, Novartis Gene Therapies has raised $2.4B in funding. The last funding round occurred on Sep 16, 2020 for $2.1B.

Novartis Gene Therapies

Biotechnology ResearchIllinois, United States1001-5000 Employees

Novartis Gene Therapies (formerly AveXis) is reimagining medicine to transform the lives of people living with rare genetic diseases. Utilizing cutting-edge technology, we are working to turn promising gene therapies into proven treatments, beginning with our transformative gene therapy for spinal muscular atrophy (SMA).

Read Our Community Guidelines: https://bit.ly/39UB7ka

How to reach us:
Novartis Gene Therapies
2275 Half Day Road, Suite 200
Bannockburn, IL 60015
Email: gtx.communications@novartis.com 
Office Phone: 847.572.8280
Toll-free Phone: 844.428.3947

Section iconCompany Overview

Headquarters
2275 Half Day Road Suite 200 Bannockburn, Illinois 60015 United States
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
1001-5000

Section iconFunding & Financials

  • $2.4B

    Novartis Gene Therapies has raised a total of $2.4B of funding over 3 rounds. Their latest funding round was raised on Sep 16, 2020 in the amount of $2.1B.

  • $25M$50M

    Novartis Gene Therapies's revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $2.4B

    Novartis Gene Therapies has raised a total of $2.4B of funding over 3 rounds. Their latest funding round was raised on Sep 16, 2020 in the amount of $2.1B.

  • $25M$50M

    Novartis Gene Therapies's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.